M1725 Food Intake and Interdigestive Gastrointestinal Motility in Ghrelin Receptor Mutant Rats

2010 ◽  
Vol 138 (5) ◽  
pp. S-406
Author(s):  
Mehmet Bulbul ◽  
Reji Babygirija ◽  
Jun Zheng ◽  
Kirk A. Ludwig ◽  
Jozef Lazar ◽  
...  
2011 ◽  
Vol 46 (4) ◽  
pp. 469-478 ◽  
Author(s):  
Mehmet Bülbül ◽  
Reji Babygirija ◽  
Jun Zheng ◽  
Kirk Ludwig ◽  
Haiyan Xu ◽  
...  

Endocrinology ◽  
2016 ◽  
Vol 157 (4) ◽  
pp. 1430-1442 ◽  
Author(s):  
Nicole H. Rogers ◽  
Heidi Walsh ◽  
Oscar Alvarez-Garcia ◽  
Seongjoon Park ◽  
Bruce Gaylinn ◽  
...  

Abstract Aging is associated with attenuated ghrelin signaling. During aging, chronic caloric restriction (CR) produces health benefits accompanied by enhanced ghrelin production. Ghrelin receptor (GH secretagogue receptor 1a) agonists administered to aging rodents and humans restore the young adult phenotype; therefore, we tested the hypothesis that the metabolic benefits of CR are mediated by endogenous ghrelin. Three month-old male mice lacking ghrelin (Ghrelin−/−) or ghrelin receptor (Ghsr−/−), and their wild-type (WT) littermates were randomly assigned to 2 groups: ad libitum (AL) fed and CR, where 40% food restriction was introduced gradually to allow Ghrelin−/− and Ghsr−/− mice to metabolically adapt and avoid severe hypoglycemia. Twelve months later, plasma ghrelin, metabolic parameters, ambulatory activity, hypothalamic and liver gene expression, as well as body composition were measured. CR increased plasma ghrelin and des-acyl ghrelin concentrations in WT and Ghsr−/− mice. CR of WT, Ghsr−/−, and Ghrelin−/− mice markedly improved metabolic flexibility, enhanced ambulatory activity, and reduced adiposity. Inactivation of Ghrelin or Ghsr had no effect on AL food intake or food anticipatory behavior. In contrast to the widely held belief that endogenous ghrelin regulates food intake, CR increased expression of hypothalamic Agrp and Npy, with reduced expression of Pomc across genotypes. In the AL context, ablation of ghrelin signaling markedly inhibited liver steatosis, which correlated with reduced Pparγ expression and enhanced Irs2 expression. Although CR and administration of GH secretagogue receptor 1a agonists both benefit the aging phenotype, we conclude the benefits of chronic CR are a consequence of enhanced metabolic flexibility independent of endogenous ghrelin or des-acyl ghrelin signaling.


2011 ◽  
Vol 94 (2) ◽  
pp. 158-168 ◽  
Author(s):  
Vivian J.A. Costantini ◽  
Elena Vicentini ◽  
Fabio M. Sabbatini ◽  
Enzo Valerio ◽  
Stefano Lepore ◽  
...  

2015 ◽  
Vol 1 ◽  
Author(s):  
Katrin Fischer ◽  
Brian Finan ◽  
Christoffer Clemmensen ◽  
Lex H. T. van der Ploeg ◽  
Matthias H. Tschöp ◽  
...  
Keyword(s):  

Endocrinology ◽  
2009 ◽  
Vol 150 (8) ◽  
pp. 3637-3644 ◽  
Author(s):  
Geyang Xu ◽  
Yin Li ◽  
Wenjiao An ◽  
Shenduo Li ◽  
Youfei Guan ◽  
...  

Ghrelin, a gastric hormone, provides a hunger signal to the central nervous system to stimulate food intake. Mammalian target of rapamycin (mTOR) is an intracellular fuel sensor critical for cellular energy homeostasis. Here we showed the reciprocal relationship of gastric mTOR signaling and ghrelin during changes in energy status. mTOR activity was down-regulated, whereas gastric preproghrelin and circulating ghrelin were increased by fasting. In db/db mice, gastric mTOR signaling was enhanced, whereas gastric preproghrelin and circulating ghrelin were decreased. Inhibition of the gastric mTOR signaling by rapamycin stimulated the expression of gastric preproghrelin and ghrelin mRNA and increased plasma ghrelin in both wild-type and db/db mice. Activation of the gastric mTOR signaling by l-leucine decreased the expression of gastric preproghrelin and the level of plasma ghrelin. Overexpression of mTOR attenuated ghrelin promoter activity, whereas inhibition of mTOR activity by overexpression of TSC1 or TSC2 increased its activity. Ghrelin receptor antagonist d-Lys-3-GH-releasing peptide-6 abolished the rapamycin-induced increment in food intake despite that plasma ghrelin remained elevated. mTOR is therefore a gastric fuel sensor whose activity is linked to the regulation of energy intake through ghrelin.


2014 ◽  
Vol 144 (9) ◽  
pp. 1349-1355 ◽  
Author(s):  
Ligen Lin ◽  
Alli M. Nuotio-Antar ◽  
Xiaojun Ma ◽  
Feng Liu ◽  
Marta L. Fiorotto ◽  
...  

Obesity ◽  
2020 ◽  
Vol 28 (8) ◽  
pp. 1503-1511
Author(s):  
Tina Bake ◽  
Marie V. Le May ◽  
Christian E. Edvardsson ◽  
Heike Vogel ◽  
Ulrika Bergström ◽  
...  

2015 ◽  
Vol 226 (1) ◽  
pp. 81-92 ◽  
Author(s):  
Farhana Naznin ◽  
Koji Toshinai ◽  
T M Zaved Waise ◽  
Cherl NamKoong ◽  
Abu Saleh Md Moin ◽  
...  

Ghrelin, a stomach-derived orexigenic peptide, transmits starvation signals to the hypothalamus via the vagus afferent nerve. Peripheral administration of ghrelin does not induce food intake in high fat diet (HFD)-induced obese mice. We investigated whether this ghrelin resistance was caused by dysfunction of the vagus afferent pathway. Administration (s.c.) of ghrelin did not induce food intake, suppression of oxygen consumption, electrical activity of the vagal afferent nerve, phosphorylation of ERK2 and AMP-activated protein kinase alpha in the nodose ganglion, or Fos expression in hypothalamic arcuate nucleus of mice fed a HFD for 12 weeks. Administration of anti-ghrelin IgG did not induce suppression of food intake in HFD-fed mice. Expression levels of ghrelin receptor mRNA in the nodose ganglion and hypothalamus of HFD-fed mice were reduced. Inflammatory responses, including upregulation of macrophage/microglia markers and inflammatory cytokines, occurred in the nodose ganglion and hypothalamus of HFD-fed mice. A HFD blunted ghrelin signaling in the nodose ganglion via a mechanism involvingin situactivation of inflammation. These results indicate that ghrelin resistance in the obese state may be caused by dysregulation of ghrelin signaling via the vagal afferent.


Sign in / Sign up

Export Citation Format

Share Document